Invention Grant
US07659057B2 Stain-directed molecular analysis for cancer prognosis and diagnosis
失效
用于癌症预后和诊断的染色体分子分析
- Patent Title: Stain-directed molecular analysis for cancer prognosis and diagnosis
- Patent Title (中): 用于癌症预后和诊断的染色体分子分析
-
Application No.: US10484420Application Date: 2002-10-05
-
Publication No.: US07659057B2Publication Date: 2010-02-09
- Inventor: Douglas D. Burkett
- Applicant: Douglas D. Burkett
- Applicant Address: US AZ Scottsdale
- Assignee: Zila Biotechnology, Inc.
- Current Assignee: Zila Biotechnology, Inc.
- Current Assignee Address: US AZ Scottsdale
- Agency: Jeffer Mangels Butler & Marmaro LLP
- International Application: PCT/US02/32067 WO 20021005
- International Announcement: WO03/072826 WO 20030904
- Main IPC: C12Q1/68
- IPC: C12Q1/68
Abstract:
The location at which tissue samples are obtained to determine whether cells exhibit characeristics associated with cell differentiation or cancer by molecular analysis is determined by topically applying to epithelial tissue a dye that selectively stains cancer and precancerous tissue.
Public/Granted literature
- US20040235067A1 Stain-directed molecular analysis for cancer prognosis and diagnosis Public/Granted day:2004-11-25
Information query
